| The promise of retinoids to fight against cancer L Altucci, H Gronemeyer Nature Reviews Cancer 1 (3), 181-193, 2001 | 850 | 2001 |
| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018 | 846 | 2018 |
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 L Galluzzi, JM Bravo-San Pedro, I Vitale, SA Aaronson, JM Abrams, ... Cell Death & Differentiation 22 (1), 58-73, 2015 | 698 | 2015 |
| Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway A Insinga, S Monestiroli, S Ronzoni, V Gelmetti, F Marchesi, A Viale, ... Nature medicine 11 (1), 71-76, 2005 | 597 | 2005 |
| Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells A Nebbioso, N Clarke, E Voltz, E Germain, C Ambrosino, P Bontempo, ... Nature medicine 11 (1), 77-84, 2005 | 545 | 2005 |
| RAR and RXR modulation in cancer and metabolic disease L Altucci, MD Leibowitz, KM Ogilvie, AR de Lera, H Gronemeyer Nature reviews Drug discovery 6 (10), 793-810, 2007 | 492 | 2007 |
| 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G (1)-arrested human breast … L Altucci, R Addeo, L Cicatiello, S Dauvois, MG Parker, M Truss, M Beato, ... Oncogene 12 (11), 2315-2324, 1996 | 430 | 1996 |
| Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL L Altucci, A Rossin, W Raffelsberger, A Reitmair, C Chomienne, ... Nature medicine 7 (6), 680-686, 2001 | 391 | 2001 |
| Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells E Habibi, AB Brinkman, J Arand, LI Kroeze, HHD Kerstens, F Matarese, ... Cell stem cell 13 (3), 360-369, 2013 | 328 | 2013 |
| Design of selective nuclear receptor modulators: RAR and RXR as a case study AR De Lera, W Bourguet, L Altucci, H Gronemeyer Nature reviews Drug discovery 6 (10), 811-820, 2007 | 258 | 2007 |
| PML-RARα/RXR alters the epigenetic landscape in acute promyelocytic leukemia JHA Martens, AB Brinkman, F Simmer, KJ Francoijs, A Nebbioso, ... Cancer cell 17 (2), 173-185, 2010 | 253 | 2010 |
| BLUEPRINT to decode the epigenetic signature written in blood D Adams, L Altucci, SE Antonarakis, J Ballesteros, S Beck, A Bird, C Bock, ... Nature biotechnology 30 (3), 224-226, 2012 | 248 | 2012 |
| Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect E Lara, A Mai, V Calvanese, L Altucci, P Lopez-Nieva, ... Oncogene 28 (6), 781-791, 2009 | 234 | 2009 |
| Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead A Mai, L Altucci The international journal of biochemistry & cell biology 41 (1), 199-213, 2009 | 223 | 2009 |
| Trials with ‘epigenetic’drugs: an update A Nebbioso, V Carafa, R Benedetti, L Altucci Molecular oncology 6 (6), 657-682, 2012 | 216 | 2012 |
| Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl) pyrrolyl hydroxyamides A Mai, S Massa, R Pezzi, S Simeoni, D Rotili, A Nebbioso, ... Journal of medicinal chemistry 48 (9), 3344-3353, 2005 | 200 | 2005 |
| HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment C Colussi, C Mozzetta, A Gurtner, B Illi, J Rosati, S Straino, G Ragone, ... Proceedings of the National Academy of Sciences 105 (49), 19183-19187, 2008 | 196 | 2008 |
| The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ... Cell 167 (5), 1145-1149, 2016 | 178 | 2016 |
| Molecular pathways involved in neural in vitro differentiation of marrow stromal stem cells FP Jori, MA Napolitano, MAB Melone, M Cipollaro, A Cascino, L Altucci, ... Journal of cellular biochemistry 94 (4), 645-655, 2005 | 174 | 2005 |
| Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor … L Cicatiello, R Addeo, A Sasso, L Altucci, VB Petrizzi, R Borgo, ... Molecular and cellular biology 24 (16), 7260-7274, 2004 | 173 | 2004 |
